It is increasingly evident that interspecies antagonism is intrinsic to life in the bacterial kingdom. The type VI secretion system (T6SS) is a complex intercellular protein delivery pathway. Though the system was initially thought to target host cells, during the prior award period our group discovered the primary function of the pathway is to deliver toxins in a cell contact-dependent manner between bacteria. Since this discovery, our group and others have learned that T6SS effectors are highly diverse. Superfamilies of effectors bearing little primary sequence identity have been described for toxins that target the peptide and carbohydrate components of the bacterial cell wall, membrane phospholipids, and DNA. Despite the potency of these toxins, many species encode multiple T6SS effectors, often with different mechanisms of action. The selective pressures driving the maintenance of diverse effector arsenals remain unknown. Additionally, while the primary function of the T6SS appears to be the delivery of toxins to competitor bacteria, several classes of effectors have been described that have targets conserved between bacteria and eukaryotes, such as phospholipids and nucleic acids. This raises the possibility that T6SS effectors could serve as a reservoir of biochemical functionality that contributes to the evolution of toxins employed by pathogens to target hosts. In this proposal, we examine both the functional consequences of effector diversity, and the connections between host and bacterial cell targeting toxins through the characterization of new effector mechanisms of action.
In Aim 1, we propose a secretion-independent, novel quantitative mass spectrometry-based approach for defining new T6S effectors.
Aim 2 focuses on the biochemical characterization of classes of effectors predicted by bioinformatics to act as ADP-ribosyltransferases, a mechanism common to many eukaryotic-targeting toxins. Finally, in Aim 3, we will employ a high throughput sequencing approach to test the hypothesis that a diverse effector repertoire promotes bacterial fitness in the face of varying environmental conditions that impact toxin efficacy. The studies outlined in this proposal stand to contribute significantly both to our basic understanding of the T6SS, and to the role that the pathway and its effectors play in bacterial pathogen fitness and evolution.

Public Health Relevance

The proposed work is expected to reveal how a widespread interbacterial competition pathway influences the organismal composition and disease outcome of polymicrobial infections such as the chronic wounds often suffered by diabetics. Our findings could lead to novel strategies for the selective eradication of pathogens from these difficult-to-treat infections.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI080609-10
Application #
9485267
Study Section
Bacterial Pathogenesis Study Section (BACP)
Program Officer
Lu, Kristina
Project Start
2009-06-17
Project End
2019-05-31
Budget Start
2018-06-01
Budget End
2019-05-31
Support Year
10
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Washington
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
LaCourse, Kaitlyn D; Peterson, S Brook; Kulasekara, Hemantha D et al. (2018) Conditional toxicity and synergy drive diversity among antibacterial effectors. Nat Microbiol 3:440-446
Ting, See-Yeun; Bosch, Dustin E; Mangiameli, Sarah M et al. (2018) Bifunctional Immunity Proteins Protect Bacteria against FtsZ-Targeting ADP-Ribosylating Toxins. Cell 175:1380-1392.e14
Verster, Adrian J; Ross, Benjamin D; Radey, Matthew C et al. (2017) The Landscape of Type VI Secretion across Human Gut Microbiomes Reveals Its Role in Community Composition. Cell Host Microbe 22:411-419.e4
Whitney, John C; Peterson, S Brook; Kim, Jungyun et al. (2017) A broadly distributed toxin family mediates contact-dependent antagonism between gram-positive bacteria. Elife 6:
Eshraghi, Aria; Kim, Jungyun; Walls, Alexandra C et al. (2016) Secreted Effectors Encoded within and outside of the Francisella Pathogenicity Island Promote Intramacrophage Growth. Cell Host Microbe 20:573-583
Wexler, Aaron G; Bao, Yiqiao; Whitney, John C et al. (2016) Human symbionts inject and neutralize antibacterial toxins to persist in the gut. Proc Natl Acad Sci U S A 113:3639-44
Whitney, John C; Quentin, Dennis; Sawai, Shin et al. (2015) An interbacterial NAD(P)(+) glycohydrolase toxin requires elongation factor Tu for delivery to target cells. Cell 163:607-19
Chou, Seemay; Daugherty, Matthew D; Peterson, S Brook et al. (2015) Transferred interbacterial antagonism genes augment eukaryotic innate immune function. Nature 518:98-101
LeRoux, Michele; Kirkpatrick, Robin L; Montauti, Elena I et al. (2015) Kin cell lysis is a danger signal that activates antibacterial pathways of Pseudomonas aeruginosa. Elife 4:
LeRoux, Michele; Peterson, S Brook; Mougous, Joseph D (2015) Bacterial danger sensing. J Mol Biol 427:3744-53

Showing the most recent 10 out of 28 publications